A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...

STORY HIGHLIGHTS Merck opens new vaccine facility in Durham. New facility will manufacture HPV vaccines Gardasil and Gardasil 9. Merck plans to invest $8 billion more in U.S. by 2028. A global ...

In a significant blow to plaintiffs suing over the HPV vaccine Gardasil, a federal judge on Tuesday sided with Merck & Co. Inc. on its implied preemption defense. More than 200 lawsuits demand ...

The HPV vaccine, called Gardasil-9 — which has no live virus and is completely non-infectious — protects against the six types of HPV most likely to cause cancer, Eckert says. (These are strains 6, 11 ...

Given the lack of solid evidence on a causal relationship between Gardasil and the two conditions, Merck didn’t possess the authority to simply change the vaccine’s label of its own accord ...

Despite this potential, the stock has fallen by 25% in the past 12 months -- so is it a bargain buy right now? During the ...

HPV, one of the most prevalent sexually transmitted infections, is the cause of nearly 36,000 cancer cases each year in the United States.

Chris Riley's symptoms started in the summer of 2021. At first, he didn't think much about them. His throat felt a little sore, and he noticed hardening of his lymph nodes. At 57 years old, Riley was ...

Within that group, biotechnology giant Amgen (NASDAQ: AMGN) has been the best-performing stock in 2025, returning an ...

Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.

A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers caused by the human papillomavirus and one of ...